Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CANCER

Optimising gene editing for cancer therapy

Gene editing holds promise for the treatment of cancers that are driven by well-characterised molecular alterations. A study now provides a proof of concept for the feasibility of in vivo gene editing to correct TERT mutations in glioblastoma, providing a platform for the direct manipulation of genetic alterations to reduce tumour growth.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: TERT promoter activity in glioblastoma tumour cells.

References

  1. Doudna, J. A. & Charpentier, E. Science 346, 1258096 (2014).

    Article  Google Scholar 

  2. Li, X. et al. Nat. Cell Biol. https://doi.org/10.1038/s41556-020-0471-6 (2020).

  3. Ostrom, Q. T. et al. Neuro-oncol. 21, v1–v100 (2019).

    Article  Google Scholar 

  4. Killela, P. J. et al. Proc. Natl Acad. Sci. USA 110, 6021–6026 (2013).

    Article  CAS  Google Scholar 

  5. Walsh, K. M. et al. Nat. Genet. 46, 731–735 (2014).

    Article  CAS  Google Scholar 

  6. Blackburn, E. H. Nature 350, 569–573 (1991).

    Article  CAS  Google Scholar 

  7. Campisi, J., Kim, S. H., Lim, C. S. & Rubio, M. Exp. Gerontol. 36, 1619–1637 (2001).

    Article  CAS  Google Scholar 

  8. Horn, S. et al. Science 339, 959–961 (2013).

    Article  CAS  Google Scholar 

  9. Bell, R. J. A. et al. Science 348, 1036–1039 (2015).

    Article  CAS  Google Scholar 

  10. Tan, J., Zhang, F., Karcher, D. & Bock, R. Nat. Commun. 10, 1 (2019).

    Article  Google Scholar 

  11. Mancini, A. et al. Cancer Cell 34, 513–528.e8 (2018).

    Article  CAS  Google Scholar 

  12. Jeong, D. E. et al. Oncol. Lett. 14, 8213–8219 (2017).

    PubMed  PubMed Central  Google Scholar 

  13. Alexandrov, L. B. et al. Nature 578, 94–101 (2020).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Justin D. Lathia.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Troike, K., Lathia, J.D. Optimising gene editing for cancer therapy. Nat Cell Biol 22, 259–261 (2020). https://doi.org/10.1038/s41556-020-0480-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41556-020-0480-5

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing